The Social Interaction Phobia Scale: Continued support for the psychometric validity of the SIPS using clinical and non-clinical samples. (May 2015)

• Record Type: Journal Article
• Authors: Menatti, Alison R.; Weeks, Justin W.; Carleton, R. Nicholas; Morrison, Amanda S.; Heimberg, Richard G.; Hope, Debra A.; Blanco, Carlos; Schneier, Franklin R.; Liebowitz, Michael R.
• Is Part Of: Journal of anxiety disorders. Volume 32(2015:May)
• Page Start: 46
• Page End: 55
• Publication Date: 2015-05
• Subjects: Anxiety -- Social anxiety disorder -- Social phobia -- Psychometric characteristics -- Social interaction anxiety -- Fear of public scrutiny; Anxiety -- Periodicals; Anxiety Disorders -- Periodicals; Angoisse -- Périodiques; Electronic journals; 616.8522
• DOI: 10.1016/j.janxdis.2015.03.003
• Languages: English
• ISSNs: 0887-6185

Abstract

Highlights: The psychometric profile of the SIPS was evaluated in three distinct samples. The SIPS demonstrated good internal consistency and construct validity. The three-factor SIPS structure was replicated in a treatment-seeking SAD sample. Cut-off scores distinguishing SAD patients from two control groups were identified. Abstract: The present study sought to extend findings supporting the psychometric validity of a promising measure of social anxiety (SA) symptoms, the Social Interaction Phobia Scale (SIPS;Carleton et al., 2009 ). Analyses were conducted using three samples: social anxiety disorder (SAD) patients, generalized anxiety disorder (GAD) patients, and healthy controls. SIPS scores of SAD patients demonstrated internal consistency and construct validity, and the previously demonstrated three-factor structure of the SIPS was replicated. Further, the SIPS total score uniquely predicted SA symptoms, and SIPS scores were significantly higher for SAD patients than GAD patients or controls. Two cut-off scores that discriminated SAD patients from GAD patients and from healthy controls were identified. The current study is the first to replicate the SIPS three-factor model in a large, treatment-seeking sample of SAD patients and establish a cut-off score discriminating SAD from GAD patients. Findings support the SIPS as a valid, SAD-specific assessment instrument.